Let’s look at the key reasons that are pushing Biolife Solutions Inc (BLFS) to new highs

On Friday, Biolife Solutions Inc (NASDAQ: BLFS) was -3.62% drop from the session before settling in for the closing price of $26.80. A 52-week range for BLFS has been $14.84 – $29.55.

Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 42.91%. When this article was written, the company’s average yearly earnings per share was at 52.57%. With a float of $45.48 million, this company’s outstanding shares have now reached $46.91 million.

Considering the fact that the conglomerate employs 159 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 64.93%, operating margin of -14.75%, and the pretax margin is -19.98%.

Biolife Solutions Inc (BLFS) Breakdown of a Key Holders of the stock

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Biolife Solutions Inc stocks. The insider ownership of Biolife Solutions Inc is 3.24%, while institutional ownership is 101.08%. The most recent insider transaction that took place on Mar 03 ’25, was worth 3,463. In this transaction Chief Technology Officer of this company sold 136 shares at a rate of $25.46, taking the stock ownership to the 4,953 shares. Before that another transaction happened on Mar 04 ’25, when Company’s Chief Technology Officer sold 88 for $24.03, making the entire transaction worth $2,115. This insider now owns 4,865 shares in total.

Biolife Solutions Inc (BLFS) Recent Fiscal highlights

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.01 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 52.57% per share during the next fiscal year.

Biolife Solutions Inc (NASDAQ: BLFS) Trading Performance Indicators

You can see what Biolife Solutions Inc (BLFS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.66. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.71. Likewise, its price to free cash flow for the trailing twelve months is 233.46.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.26, a number that is poised to hit -0.05 in the next quarter and is forecasted to reach 0.12 in one year’s time.

Technical Analysis of Biolife Solutions Inc (BLFS)

Compared to the last year’s volume of 0.28 million, its volume of 0.5 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 66.53%. Additionally, its Average True Range was 1.57.

During the past 100 days, Biolife Solutions Inc’s (BLFS) raw stochastic average was set at 63.13%, which indicates a significant increase from 44.32% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 48.68% in the past 14 days, which was lower than the 50.87% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $26.63, while its 200-day Moving Average is $24.35. Nevertheless, the first resistance level for the watch stands at $26.69 in the near term. At $27.54, the stock is likely to face the second major resistance level. The third major resistance level sits at $28.07. If the price goes on to break the first support level at $25.31, it is likely to go to the next support level at $24.78. Now, if the price goes above the second support level, the third support stands at $23.93.

Biolife Solutions Inc (NASDAQ: BLFS) Key Stats

There are 47,000K outstanding shares of the company, which has a market capitalization of 1.21 billion. As of now, sales total 143,270 K while income totals -66,430 K. Its latest quarter income was 30,570 K while its last quarter net income were -1,700 K.